119 related articles for article (PubMed ID: 17022146)
1. Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.
Aoki D; Suzuki N; Susumu N; Noda T; Suzuki A; Tamada Y; Higashiguchi A; Oie S; Nozawa S
Hum Cell; 2005 Sep; 18(3):143-6. PubMed ID: 17022146
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary.
Ohyama A; Toyomura J; Tachibana T; Isonishi S; Takahashi H; Ishikawa H
Hum Cell; 2016 Oct; 29(4):188-96. PubMed ID: 27541369
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.
Itamochi H; Kato M; Nishimura M; Oumi N; Oishi T; Shimada M; Sato S; Naniwa J; Sato S; Nonaka M; Kudoh A; Terakawa N; Kigawa J; Harada T
Hum Cell; 2013 Sep; 26(3):121-7. PubMed ID: 23430509
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA.
Hoshino H; Inoue D; Shinagawa A; Yoshida H; Shigeto S; Matsuda K; Akama TO; Yoshida Y; Kobayashi M
Hum Cell; 2024 Jul; 37(4):1184-1193. PubMed ID: 38573494
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary.
Yamada T; Hattori K; Satomi H; Okazaki T; Mori H; Hirose Y
J Ovarian Res; 2016 Jun; 9(1):32. PubMed ID: 27259990
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.
Sato S; Itamochi H; Oumi N; Chiba Y; Oishi T; Shimada M; Sato S; Chikumi J; Nonaka M; Kudoh A; Komatsu H; Harada T; Sugiyama T
Hum Cell; 2016 Oct; 29(4):181-7. PubMed ID: 26960408
[TBL] [Abstract][Full Text] [Related]
7. POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary.
Yoshioka N; Suzuki N; Uekawa A; Kiguchi K; Ishizuka B
Hum Cell; 2009 Nov; 22(4):94-100. PubMed ID: 19874398
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary.
Yamada K; Tachibana T; Hashimoto H; Suzuki K; Yanagida S; Endoh H; Kimura E; Yasuda M; Tanaka T; Ishikawa H
Hum Cell; 1999 Sep; 12(3):131-8. PubMed ID: 10695020
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of human ovarian clear cell adenocarcinoma cell line (SMOV-2), and its cytotoxity by anticancer agents.
Yonamine K; Hayashi K; Iida T
Hum Cell; 1999 Sep; 12(3):139-48. PubMed ID: 10695021
[TBL] [Abstract][Full Text] [Related]
10. Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.
Suzuki N; Higashiguchi A; Hasegawa Y; Matsumoto H; Oie S; Orikawa K; Ezawa S; Susumu N; Miyashita K; Aoki D
Hum Cell; 2005 Sep; 18(3):147-55. PubMed ID: 17022147
[TBL] [Abstract][Full Text] [Related]
11. [Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line].
Sasa H; Ishii K; Hirata J; Kikuchi Y; Nagata I; Kawai T; Senoo A; Sugita M; Sugishita T; Tenjin Y
Hum Cell; 1993 Dec; 6(4):279-86. PubMed ID: 8148309
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary.
Yabushita H; Ueno N; Sawaguchi K; Higuchi K; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):888-94. PubMed ID: 2794621
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma.
Wong WS; Wong YF; Ng YT; Huang PD; Chew EC; Ho TH; Chang MZ
Gynecol Oncol; 1990 Jul; 38(1):37-45. PubMed ID: 2354825
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a human malignant choroids plexus papilloma cell line (HIBCPP).
Ishiwata I; Ishiwata C; Ishiwata E; Sato Y; Kiguchi K; Tachibana T; Hashimoto H; Ishikawa H
Hum Cell; 2005 Mar; 18(1):67-72. PubMed ID: 16130902
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning--with special reference to the stem cell of the tumor.
Nozawa S; Tsukazaki K; Sakayori M; Jeng CH; Iizuka R
Hum Cell; 1988 Dec; 1(4):426-35. PubMed ID: 3154025
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties.
Gorai I; Nakazawa T; Miyagi E; Hirahara F; Nagashima Y; Minaguchi H
Gynecol Oncol; 1995 Apr; 57(1):33-46. PubMed ID: 7535723
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component).
Ishiwata I; Ishiwata C; Soma M; Ishikawa H
Gynecol Oncol; 1986 Sep; 25(1):95-107. PubMed ID: 3732924
[TBL] [Abstract][Full Text] [Related]
18. A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.
Suzuki N; Aoki D; Oie S; Horiuchi M; Hasegawa Y; Ezawa S; Suzuki A; Susumu N; Hosoi F; Kitazato K; Nozawa S
Gynecol Oncol; 2004 Sep; 94(3):643-9. PubMed ID: 15350353
[TBL] [Abstract][Full Text] [Related]
19. Selection of human ovarian carcinoma cells with high dissemination potential by repeated passage of the cells in vivo into nude mice, and involvement of Le(x)-determinant in the dissemination potential.
Kiguchi K; Iwamori M; Mochizuki Y; Kishikawa T; Tsukazaki K; Saga M; Amemiya A; Nozawa S
Jpn J Cancer Res; 1998 Sep; 89(9):923-32. PubMed ID: 9818028
[TBL] [Abstract][Full Text] [Related]
20. Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1).
Jiang W; Ye S; Xiang L; Yang W; He T; Pei X; Guo L; Yang H
J Ovarian Res; 2018 Jul; 11(1):58. PubMed ID: 29986747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
